Abivax (AAVXF) Convertible Debt (2023 - 2025)

Abivax has reported Convertible Debt for 3 years, with the latest figure at $42.8 million in Q4 2025.

• On a quarterly basis, Convertible Debt rose 85.56% year-over-year to $42.8 million in Q4 2025; TTM through Dec 2025 was $42.8 million, a 85.56% increase from a year earlier, with the FY2025 full-year figure at $42.8 million, up 85.56% from the prior year.
• Convertible Debt was $42.8 million for Q4 2025 at Abivax, up from $28.1 million in the prior quarter.
• The five-year high for Convertible Debt was $42.8 million in Q4 2025, with the low at $22.2 million in Q4 2023.
• Average Convertible Debt over 3 years is $29.0 million, with a median of $25.6 million recorded in 2024.
• The sharpest annual moves came in 2024 and 2025: Convertible Debt gained 3.75% in 2024, then jumped 85.56% in 2025.
• Over 3 years, Convertible Debt stood at $22.2 million in 2023, then increased by 3.75% to $23.1 million in 2024, then surged by 85.56% to $42.8 million in 2025.
• The last three Convertible Debt figures came in at $42.8 million (Q4 2025), $28.1 million (Q3 2025), and $23.1 million (Q4 2024), per Business Quant data.